Results 101 to 110 of about 11,802 (200)
Carbapenem-resistant Enterobacterales in wastewater resources and healthy carriers: A survey in Iran
The carbapenem-resistant Enterobacterales (CRE) pose a pressing public health concern. Here, we investigated the frequency of CRE bacteria, carbapenemase-encoding genes, and the molecular epidemiology of carbapenemase-resistant Escherichia coli in ...
Shabnam Khavandi +4 more
doaj +1 more source
This study demonstrated the incidences of hospital-acquired colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and vancomycin-resistant enterococci (VRE) of 22%, 8%, and 8 ...
Tutchaphol Rattanon +2 more
doaj +1 more source
Background and Objectives: Carbapenem-resistant Enterobacterales (CRE) pose a major healthcare challenge due to high resistance rates and limited treatment options.
Touseefa Shafi +6 more
doaj +1 more source
Supplemental material, sj-docx-1-tai-10.1177_20499361221080650 for Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae by Raunak Bir, Hitender Gautam, Nazneen Arif, Priyanka Chakravarti, Jyoti Verma ...
Rama Chaudhry (846553) +13 more
core +1 more source
The COVID-19 pandemic led to an initial increase in the incidence of carbapenem-resistant Enterobacterales (CRE) from clinical cultures in South-East Asia hospitals, which was unsustained as the pandemic progressed.
Say Tat Ooi +47 more
core +1 more source
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales : a nested case-control-control study [PDF]
: Background Carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) are a major threat to patients. To date, data on risk factors have been limited, with low internal and external validity.
Perez-Galera, Salvador +22 more
core +4 more sources
Objectives: To evaluate the in vitro susceptibility of ESBL-producing Enterobacterales isolates to ceftolozane/tazobactam (C/T), a combination of tazobactam (a ß-lactamase inhibitor) and a new antipseudomonal cephalosporin.
Wei Yu +6 more
doaj +1 more source
BACKGROUND: Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (
Ge, Lizhao +15 more
core +2 more sources
Introduction: Urinary tract infections are common in both hospital and community settings and impose a significant financial burden. Among Enterobacterales, Escherichia coli and Klebsiella pneumoniae are the leading uropathogens.
Gaurav Verma +7 more
doaj +1 more source
Eman E Hegazy,1 Marwa Gamal Bahey,1 Alaa Mohammed Abo Hagar,2 Amira Abdelgalil Elkholy,3 Esraa A Mohamed1 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Tanta University, Tanta, Egypt; 2Department of Anesthesiology, Surgical ...
Hegazy EE +4 more
doaj

